Bruni A, Monastra G, Bellini F, Toffano G
Department of Pharmacology, University of Padova, Italy.
Prog Clin Biol Res. 1988;282:165-79.
The hypothesis of this study is summarized in Fig. 6. Phosphatidylserine due to distribution in the internal side of plasma membrane is prevented to react with the extracellular environment. When injury to cell occurs, phospholipid asymmetry is lost and the exposed phosphatidylserine becomes a signal of cell damage. Phosphatidylserine may activate defense reactions while it is still anchored to plasma membrane (Zwaal, 1978; Tanaka and Schroit, 1983). Alternatively, the soluble lysophosphatidylserine is generated, ready to diffuse and transmit the information of tissue damage to other cells. In this sequence of events, lysophosphatidylserine becomes an autacoid, originated from a membrane phospholipid. In rodents, lysophosphatidylserine seems specifically devoted to activate mast cells. The role of these cells in the regulation of the immune reactions and in tissue repair has been advocated (Dexter et al., 1981). The lysophosphatidylserine-induced mast cell activation has been shown in vivo and in vitro in a variety of rodent species (mouse, rat, gerbil, hamster). It may occur through a direct effect or through the participation of synergistic endogenous compounds. Structure-activity relationships in the action of lysophosphatidylserine show that the effect on mast cells is linked to a definite molecular organization. Determinants of the mast cell activation are the free amino group and the carboxyl group of the serine. Support to the general hypothesis of this study originates from the observation that active lysophosphatidylserine is generated within a population of leukocytes, the cells migrating in areas of wounded tissue (Mietto et al., 1987). Production of lysophosphatidylserine can be anticipated in pathological situations associated with extensive cell death (tumor growth, graft rejection, burns). At present, the observations on lysophosphatidylserine are confined to rodent mast cells. Other histamine-secreting cells (e.g., the human basophil) are unresponsive to this phospholipid (Kolster et al., 1987). Among the endogenous compounds interacting with lysophosphatidylserine, nerve growth factor seems of particular interest (Bruni et al., 1982). The synergism with lysophosphatidylserine has been confirmed in other laboratories (Sugiyama et al., 1985; Pearce and Thompson, 1986; Mazurek et al., 1986). The concerted effects by these two compounds on mast cells is in line with current opinion on the participation of nerve growth factor in the regulation of inflammatory and immune reactions (Mietto et al., 1987; Weskamp and Otten, 1987).(ABSTRACT TRUNCATED AT 400 WORDS)
本研究的假设总结于图6。由于磷脂酰丝氨酸分布在质膜内侧,可防止其与细胞外环境发生反应。当细胞受到损伤时,磷脂不对称性丧失,暴露的磷脂酰丝氨酸成为细胞损伤的信号。磷脂酰丝氨酸在仍锚定在质膜上时可能激活防御反应(兹瓦尔,1978年;田中与施罗伊特,1983年)。或者,会生成可溶性溶血磷脂酰丝氨酸,其随时准备扩散并将组织损伤信息传递给其他细胞。在这一系列事件中,溶血磷脂酰丝氨酸成为一种自分泌物质,源自膜磷脂。在啮齿动物中,溶血磷脂酰丝氨酸似乎专门用于激活肥大细胞。这些细胞在免疫反应调节和组织修复中的作用已得到提倡(德克斯特等人,1981年)。溶血磷脂酰丝氨酸诱导的肥大细胞激活已在多种啮齿动物物种(小鼠、大鼠、沙鼠、仓鼠)的体内和体外得到证实。它可能通过直接作用或通过协同内源性化合物的参与而发生。溶血磷脂酰丝氨酸作用中的构效关系表明,对肥大细胞的作用与特定的分子结构有关。肥大细胞激活的决定因素是丝氨酸的游离氨基和羧基。对本研究总体假设的支持源于以下观察结果:在一群白细胞(即迁移到受伤组织区域的细胞)中会生成活性溶血磷脂酰丝氨酸(米耶托等人,1987年)。在与广泛细胞死亡相关的病理情况(肿瘤生长、移植排斥、烧伤)中,可以预期会产生溶血磷脂酰丝氨酸。目前,关于溶血磷脂酰丝氨酸的观察仅限于啮齿动物肥大细胞。其他组胺分泌细胞(例如人类嗜碱性粒细胞)对这种磷脂无反应(科尔斯特等人,1987年)。在与溶血磷脂酰丝氨酸相互作用的内源性化合物中,神经生长因子似乎特别值得关注(布鲁尼等人,1982年)。与溶血磷脂酰丝氨酸的协同作用已在其他实验室得到证实(杉山等人,1985年;皮尔斯与汤普森,1986年;马祖雷克等人,1986年)。这两种化合物对肥大细胞的协同作用与当前关于神经生长因子参与炎症和免疫反应调节的观点一致(米耶托等人,1987年;韦斯科姆与奥滕,1987年)。(摘要截取自400字)